s6y
Company name or ticker
Search
CymaBay Therapeutics, Inc.
8-K
Director or officer change; Shareholder vote results
Filed
Thursday, June 7, 2018
Period
Jun 5, 2018
Accession number
0001193125-18-186789
Documents
Current report filing
8-K
Exhibits
10.1
Material contract
EX-10.1
On sec.gov
Filing index
All files
Complete submission text
SGML header